GSA Capital Partners LLP lowered its stake in shares of TriMas Co. (NASDAQ:TRS – Free Report) by 16.5% during the third quarter, HoldingsChannel reports. The institutional investor owned 28,110 shares of the industrial products company’s stock after selling 5,543 shares during the quarter. GSA Capital Partners LLP’s holdings in TriMas were worth $718,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its holdings in shares of TriMas by 1.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,145,236 shares of the industrial products company’s stock worth $80,298,000 after purchasing an additional 51,701 shares in the last quarter. Quest Partners LLC grew its stake in TriMas by 275.2% during the second quarter. Quest Partners LLC now owns 33,267 shares of the industrial products company’s stock worth $850,000 after buying an additional 24,400 shares in the last quarter. Impax Asset Management Group plc increased its holdings in TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock valued at $10,467,000 after buying an additional 280,431 shares during the period. American Century Companies Inc. raised its position in shares of TriMas by 12.5% in the 2nd quarter. American Century Companies Inc. now owns 65,505 shares of the industrial products company’s stock valued at $1,674,000 after buying an additional 7,304 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of TriMas by 2.3% during the 1st quarter. Vanguard Group Inc. now owns 4,358,524 shares of the industrial products company’s stock worth $116,503,000 after acquiring an additional 100,068 shares during the period. Institutional investors own 99.42% of the company’s stock.
TriMas Trading Down 0.2 %
Shares of TriMas stock opened at $25.54 on Monday. The firm’s 50 day moving average is $26.15 and its 200 day moving average is $25.86. The firm has a market capitalization of $1.04 billion, a PE ratio of 39.91 and a beta of 0.66. TriMas Co. has a 1 year low of $22.45 and a 1 year high of $28.51. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60.
TriMas Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 12th. Stockholders of record on Tuesday, November 5th were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend was Tuesday, November 5th. TriMas’s payout ratio is 25.00%.
Analyst Upgrades and Downgrades
Several research analysts have commented on TRS shares. BWS Financial restated a “buy” rating and set a $40.00 price objective on shares of TriMas in a research report on Tuesday, November 5th. StockNews.com raised TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.
View Our Latest Research Report on TRS
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories
- Five stocks we like better than TriMas
- What Are Dividend Champions? How to Invest in the Champions
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 5 Top Rated Dividend Stocks to Consider
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Stock Market Upgrades: What Are They?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.